-
effectivehealthcare-admin.ahrq.gov/products/pqmp/protocol
August 01, 2024 - Have any of these studies shown improvements in quality of care, improvements in health outcomes, or … ] OR “process measure”[tiab] OR “process measures”[tiab] OR “quality improvement”[tiab] OR “quality improvements
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-conventional-ct-mdct-including-virtual-ct-bronchoscopy-petpet-ct-and-mri-for-the-diagnosis-or-pretreatment-staging-of-small-cell-and-non-small-cell-lung-cancer
November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-does-mass-spectrometric-analysis-and-therapeutic-monitoring-of-tacrolimus-as-compared-with-immunoassay-analysis-and-therapeutic-monitoring-produce-a-better-organ-survival-rate-b-fewer-rejections-c-less-nephrotoxicity-andor
November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/description-of-a-question-or-questions-about-a-health-care-test-or-treatment-o-in-women-with-leiomyomas-who-are-candidates-for-surgery-does-the-use-of-adjunctive-medical-treatment-result-in-better-outcomes-preoperative-adjuv
November 01, 2017 - For example, improvements in symptoms or problems with diagnosis.
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-evidence-exists-for-programs-to-increase-patient-adherence-to-prescription-medications-which-programsapproaches-are-most-effective-at-increasing-adherence-for-which-populations-and-conditions-if-little-or-no-evidence-ex
November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-patients-with-pku-there-is-now-a-pharmaceutical-drug-to-treat-this-condition-in-the-past-is-was-treated-by-medical-foods-that-eliminated-the-harmful-substance-phenylalanine-the-cost-of-the-new-drug-is-70k-year-the-cost-t
November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-low-back-painbr-key-questionsbr-olliin-patients-with-low-back-pain-what-are-the-benefits-and-harms-of-identifying-risk-factors-for-chronicity-and-targeting-treatment-based-on-assessed-riskliliin-pa
November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-are-the-best-practice-behavioral-health-programs-for-type-1-diabetes-type-2-diabetes-and-gestational-diabetes-does-educational-counseling-help-paitients-improve-control-and-adherence-to-treatment
November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-patients-with-crohns-disease-what-treatments-or-therapies-alone-or-in-conjunction-with-one-another-provide-the-highest-rate-of-disease-management-with-the-lowest-risk-of-long-term-complications-particularly-in-young-wome
November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/mindfulness-meditation-encompasses-a-range-of-meditation-techniques-that-have-been-increasingly-used-to-treat-behavioral-disorders-especially-those-associated-with-stress-some-of-these-were-previously-described-in-ahrq-publi
November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-what-are-the-benefits-and-harms-of-rhythm-control-compared-to-rate-control-including-newer-agents-what-are-the-benefits-and-harms-of-strict-vs-more-lenient-rate-control-2-what-are-the-benefits-and-harms-of-different-antico
November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/how-can-patients-who-have-chronic-diseases-better-prepare-for-critical-illness-and-the-end-of-life-will-a-decision-aid-using-individualized-estimates-of-outcomes-help-shared-decision-making-about-advance-care-planning
November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/machine-learning-tools-appendix-d.xlsx
January 01, 2024 - Whilst promising, the percentage of correct responses is still unsatisfactory and therefore substantial improvements … Whilst promising, the percentage of correct responses is still unsatisfactory and therefore substantial improvements … Whilst promising, the percentage of correct responses is still unsatisfactory and therefore substantial improvements … Whilst promising, the percentage of correct responses is still unsatisfactory and therefore substantial improvements
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - biologic
DMARDs:
Better
improvements
in
disease
activity
from
combination … Patients with moderate RA had significant
improvements and better overall functional
status than those … with severe RA, but those
with severe RA had the greatest improvements
from baseline in disease activity … Patients with moderate RA had significant improvements
and better overall functional status than those … with
severe RA, but those with severe RA had the greatest
improvements from baseline in disease activity
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - biologic
DMARDs:
Better
improvements
in
disease
activity
from
combination … Patients with moderate RA had significant
improvements and better overall functional
status than those … with severe RA, but those
with severe RA had the greatest improvements
from baseline in disease activity … Patients with moderate RA had significant improvements
and better overall functional status than those … with
severe RA, but those with severe RA had the greatest
improvements from baseline in disease activity
-
effectivehealthcare-admin.ahrq.gov/products/telehealth/technical-brief
January 01, 2020 - counseling or remote monitoring in chronic conditions such as cardiovascular and respiratory disease, with improvements
-
effectivehealthcare-admin.ahrq.gov/products/asthma-nonpharmacologic-treatment/thermoplasty-systematic-review
October 01, 2019 - The sham-controlled, blinded study found modest improvements in severe exacerbations and significantly
-
effectivehealthcare-admin.ahrq.gov/products/alzheimers-type-dementia/research
October 01, 2022 - Regardless of CATD severity, cholinesterase-inhibitors produced small improvements in cognition and function
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
December 01, 2015 - Have improvements in intermediate outcomes (SVR, histologic changes) been shown to
reduce the risk or … KQ 4:
Have improvements in intermediate outcomes (viremia, liver function tests, histologic
changes … KQ 4: Have improvements in intermediate outcomes (viremia, liver function tests,
histologic changes) … KQ 4: Have improvements in intermediate outcomes (viremia, liver function tests, histologic
changes) … Key Question 4:
Have improvements in intermediate outcomes been shown to reduce risk or rates of adverse
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
December 01, 2015 - Have improvements in intermediate outcomes (SVR, histologic changes) been shown to
reduce the risk or … KQ 4:
Have improvements in intermediate outcomes (viremia, liver function tests, histologic
changes … KQ 4: Have improvements in intermediate outcomes (viremia, liver function tests,
histologic changes) … KQ 4: Have improvements in intermediate outcomes (viremia, liver function tests, histologic
changes) … Key Question 4:
Have improvements in intermediate outcomes been shown to reduce risk or rates of adverse